These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6260313

  • 1. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE, Glorieux FH.
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [Abstract] [Full Text] [Related]

  • 2. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF.
    Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D metabolism in hypophosphatemic rickets.
    Mason RS, Rohl PG, Lissner D, Posen S.
    Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
    [Abstract] [Full Text] [Related]

  • 4. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR, Reade TM, DeLuca HF, Hamstra AJ.
    N Engl J Med; 1978 Nov 02; 299(18):976-9. PubMed ID: 308618
    [Abstract] [Full Text] [Related]

  • 5. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH, Marie PJ, Pettifor JM, Delvin EE.
    N Engl J Med; 1980 Oct 30; 303(18):1023-31. PubMed ID: 6252463
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 30; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 7. Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D.
    Chesney RW, Hamstra AJ, DeLuca HF.
    Am J Dis Child; 1981 Jan 30; 135(1):34-7. PubMed ID: 6969986
    [Abstract] [Full Text] [Related]

  • 8. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS, Piel CF, Gordan GS.
    Trans Assoc Am Physicians; 1972 Jan 30; 85():172-80. PubMed ID: 4349621
    [No Abstract] [Full Text] [Related]

  • 9. Vitamin D metabolite concentrations in vitamin D deficiency. Are calcitriol levels normal.
    Chesney RW, Zimmerman J, Hamstra A, DeLuca HF, Mazees RB.
    Am J Dis Child; 1981 Nov 30; 135(11):1025-8. PubMed ID: 6271009
    [Abstract] [Full Text] [Related]

  • 10. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL.
    Pediatrics; 1983 Apr 30; 71(4):559-67. PubMed ID: 6300745
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D and vitamin D dependency.
    Tsuchiya Y, Matsuo N, Cho H, Tsubouchi K, Kumagai M, Nishii Y, Nanjoh M, Yamamoto T.
    Contrib Nephrol; 1980 Apr 30; 22():89-100. PubMed ID: 6967387
    [Abstract] [Full Text] [Related]

  • 12. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, Guillozo H, Grimberg R, Le Deunff MJ, Lieberherr M, Guimbaud P, Broyer M, Marx SJ.
    J Clin Endocrinol Metab; 1983 Oct 30; 57(4):803-11. PubMed ID: 6309886
    [Abstract] [Full Text] [Related]

  • 13. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
    Yamaoka K, Tanaka H, Kurose H, Shima M, Ozono K, Nakajima S, Seino Y.
    Bone Miner; 1989 Sep 30; 7(2):159-69. PubMed ID: 2804451
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
    Beer S, Tieder M, Kohelet D, Liberman OA, Vure E, Bar-Joseph G, Gabizon D, Borochowitz ZU, Varon M, Modai D.
    Clin Endocrinol (Oxf); 1981 Apr 30; 14(4):395-402. PubMed ID: 6266702
    [Abstract] [Full Text] [Related]

  • 15. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE, Drezner MK, Hamdan JA, Mange M, Ahmad MS, Mubarak S, Nyhan WL.
    J Pediatr; 1986 Dec 30; 109(6):994-1000. PubMed ID: 3023599
    [Abstract] [Full Text] [Related]

  • 16. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets.
    Bettinelli A, Bianchi ML, Mazzucchi E, Gandolini G, Appiani AC.
    J Pediatr; 1991 Mar 30; 118(3):372-6. PubMed ID: 1847972
    [Abstract] [Full Text] [Related]

  • 17. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH.
    Metabolism; 1990 Apr 30; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [Abstract] [Full Text] [Related]

  • 18. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Calcif Tissue Int; 1982 Mar 30; 34(2):158-64. PubMed ID: 6282410
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C, Porath A, Berelowitz M, Marshall L, Favus MJ.
    J Clin Endocrinol Metab; 1980 Nov 30; 51(5):1180-3. PubMed ID: 6893459
    [Abstract] [Full Text] [Related]

  • 20. Plasma concentrations of vitamin D metabolites before and during treatment of vitamin D deficiency rickets in children.
    Markestad T, Halvorsen S, Halvorsen KS, Aksnes L, Aarskog D.
    Acta Paediatr Scand; 1984 Mar 30; 73(2):225-31. PubMed ID: 6331057
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.